462 unknown. 462 Phase 3, 100 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 462 | Unknown 462 |
| Phase 2 | 100 | Unknown 100 |
Follow Gastrointestinal Diseases: new trials by email Literature Review of Gastrointestinal Diseases trials Research Report on Gastrointestinal Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial to Investigate the Efficacy and Safety of Ondansetron (Danset - Adwia) Versus Placebo Plus the Standard of Care in the Treatment of Nausea and Vomiting in Adult Patients With Acute Gastroenteritis Ondansetron 8 mg ampoule, Metoclopramide 10 mg ampoule - Gastroenteritis | Phase 3 | Unknown | Genuine Research Center, Egypt | 126 | 2025-06-01 | 2024-09-26 |
| Chemopreventive Effect of Combination of Celecoxib and Metformin in Patients With Familial Adenomatous Polyposis celecoxib monotherapy, celecoxib and metformin combination - Familial Adenomatous Polyposis | Phase 3 | Unknown | Yonsei University | 28 | 2024-08-13 | 2024-08-09 |
| Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous as Induction Therapy in Patients With Active CD or UC CT-P13 - Inflammatory Bowel Diseases | Phase 3 | Unknown | CMC Ambroise Paré | 130 | 2024-07-10 | 2024-07-31 |
| Reducing Inflammatory Syndrome in Surgery - Colorectal (RISIS-CR) Trial Alpha-ketoglutarate, Placebo, Standard care - Colorectal Cancer | Phase 3 | Unknown | National University Hospital, Singapore | 80 | 2024-05-09 | 2024-10-17 |
| Unravelling Intestinal Fibrosis in Ulcerative Colitis Fibroblast Activation Protein Inhibitor - Ulcerative Colitis (UC), Inflammatory Bowel Disease (IBD) | Phase 2 / Phase 3 | Unknown | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 10 | 2024-04-03 | 2024-09-19 |
| Phase III Multicentre Trial of Oral Mesalazine in Patients With Mild to Moderate Ulcerative Colitis. Mesalazine - Colitis, Ulcerative | Phase 3 | Unknown | Faes Farma, S.A. | 376 | 2024-03-01 | 2023-12-19 |
| Proactive Management of Endoperitoneal Spread in Colonic Cancer Standard surgical treatment, Proactive management, Standard adjuvant systemic chemotherapy - Colon Cancer, Intraperitoneal Rectal Cancer | Phase 3 | Unknown | University of Roma La Sapienza | 140 | 2024-03-01 | 2023-05-06 |
| Postoperative Immune Maintenance Therapy for Esophageal Squamous Cell Carcinoma After Radical Resection sintilimab - Esophageal Squamous Cell Carcinoma Thoracic Stage II, Esophageal Squamous Cell Carcinoma Thoracic Stage III | Phase 3 | Unknown | Fujian Medical University Union Hospital | 400 | 2024-01-10 | 2023-12-08 |
| Clinical Study of Dexmedetomidine Administered Intranasally to Relieve Perioperative Anxiety and Depression in Patients With Colorectal Tumors Dexmedetomidine administered intranasally - Colorectal Cancer | Phase 3 | Unknown | First Affiliated Hospital of Chongqing Medical University | 126 | 2023-12-01 | 2024-04-09 |
| EffiCacy and sAfEty of Low doSe orAl iRon for Anaemia in IBD Ferrous fumarate syrup 2.5ml/70mg (22.5mg elemental iron), Ferrous fumarate syrup 2.5ml/70mg(45mg elemental iron), Ferrous fumarate syrup 2.5ml/70mg (90mg elemental iron) - Inflammatory Bowel Disease, Iron Deficiency Anemia | Phase 3 | Unknown | Liverpool University Hospitals NHS Foundation Trust | 30 | 2023-10-20 | 2024-03-20 |
| Sulfasalazine in Patients With Metastatic Colorectal Cancer Sulfasalazine - Metastatic Colorectal Cancer | Phase 3 | Unknown | Tanta University | 50 | 2023-09-01 | 2023-11-18 |
| Neoadjuvant Chemotherapy With PD-1 Inhibitors Combined With SIB-IMRT in the Treatment of Locally Advanced Rectal Cancer Tislelizumab, Capecitabine, Oxaliplatin - Rectal Neoplasms | Phase 3 | Unknown | Yong Zhang,MD | 48 | 2023-09-01 | 2023-10-11 |
| Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non-Erosive Gastroesophageal Reflux Disease (NERD) DWP14012 20mg, DWP14012 40mg, Placebo - Non-erosive Reflux Disease, Non-Erosive Gastro-Esophageal Reflux Disease | Phase 3 | Unknown | Daewoong Pharmaceutical Co. LTD. | 324 | 2023-08-31 | 2023-11-08 |
| Efficacy, Safety and Immunogenicity of the Proposed Biosimilar Vedolizumab PB016 in Comparison With Entyvio® Intravenous (IV) infusions - Ulcerative Colitis | Phase 3 | Unknown | Polpharma Biologics S.A. | 750 | 2023-07-24 | 2025-06-17 |
| Cetuximab+mFOLFOX6 VS. mFOLFOX6 Alone in RAS/BRAF Wild Type Patients With High-Risk Resectable CRLM mFOLFOX6 + Cetuximab, mFOLFOX 6 - Colorectal Cancer, Liver Metastases | Phase 3 | Unknown | Fudan University | 250 | 2023-07-15 | 2023-07-17 |
| A Study to Evaluate Safety and Efficacy of PBK_M2101 PBK_M2101 2-Day, PBK_M2101 1-Day, Oral Sulfate Tablet 2-Day - Intestinal Disease, Colonic Diseases | Phase 3 | Unknown | Pharmbio Korea Co., Ltd. | 246 | 2023-06-01 | 2023-06-28 |
| A Study to Evaluate Endoscopic Visibility of Stomach After a Combination Drink of N-acetylcysteine and Simethicone Evaluation of gastric visibility following the combination drink of N-acetyle cysteine and simethocone - Gastric Disease | Phase 3 | Unknown | Sanjay Gandhi Postgraduate Institute of Medical Sciences | 200 | 2023-04-01 | 2023-04-06 |
| Polidocanol Foam in Hemorrhoidal Disease in Patients With Liver Cirrhosis Polidocanol foam sclerotherapy - Hemorrhoids, Liver Cirrhosis | Phase 2 / Phase 3 | Unknown | Universidade do Porto | 40 | 2023-03-31 | 2023-04-11 |
| Nitazoxanide in Patients With Metastatic Colorectal Cancer Nitazoxanide - Metastatic Colorectal Cancer | Phase 3 | Unknown | Tanta University | 60 | 2023-03-01 | 2023-09-22 |
| PD-1 Antibody Combined With mXELIRI Versus mXELIRI in the Second-line Setting for ESCC PD-1 Inhibitors, Irinotecan, Capecitabine tablets - Esophageal Squamous Cell Carcinoma Abdominal Stage 0 | Phase 3 | Unknown | Sun Yat-sen University | 380 | 2023-02-17 | 2024-01-23 |
Showing 20 of 462. Sign in to see all of them.
Colorectal Neoplasms (117) · Stomach Neoplasms (82) · Rectal Neoplasms (65) · Colonic Neoplasms (54) · Esophageal Neoplasms (40) · Crohn Disease (24) · Colitis, Ulcerative (23) · Esophageal Squamous Cell Carcinoma (18) · Neoplasm Metastasis (16) · Inflammatory Bowel Diseases (13) · Gastroesophageal Reflux (11) · Irritable Bowel Syndrome (10) · Mucositis (10) · Hemorrhoids (9) · Gastrointestinal Hemorrhage (7)
Digestive System Diseases (459) · Neoplasms by Site (325) · Digestive System Neoplasms (323) · Neoplasms (323) · Gastrointestinal Neoplasms (321) · Intestinal Diseases (277) · Intestinal Neoplasms (190) · Colonic Diseases (187) · Rectal Diseases (172) · Stomach Diseases (90) · Pathological Conditions, Signs and Symptoms (76) · Colorectal Neoplasms (73) · Esophageal Diseases (73) · Gastroenteritis (72)
Oxaliplatin (52) · Capecitabine (44) · Fluorouracil (44) · Leucovorin (35) · Radiotherapy (21) · Irinotecan (20) · Drug Therapy (17) · Paclitaxel (16) · Cisplatin (15) · XELOX (14) · Cetuximab (12) · Chemotherapy, Adjuvant (11) · Folfox protocol (11) · Neoadjuvant Therapy (11) · Radiation (11)
Fudan University (23) · Sun Yat-sen University (20) · Sixth Affiliated Hospital, Sun Yat-sen University (13) · Chinese Academy of Medical Sciences (9) · Chinese University of Hong Kong (9) · Tianjin Medical University Cancer Institute and Hospital (8) · The First Affiliated Hospital of Henan University of Science and Technology (7) · Samsung Medical Center (6) · Tanta University (6) · Blokhin's Russian Cancer Research Center (5) · National Taiwan University Hospital (5) · Shanghai Zhongshan Hospital (5) · West China Hospital (5) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (4) · Asian Institute of Gastroenterology, India (4)
China (178) · South Korea (26) · Italy (22) · France (20) · Netherlands (18) · United States (18) · United Kingdom (16) · Germany (13) · India (13) · Taiwan (13) · Canada (10) · Egypt (10) · Japan (10) · Israel (8) · Poland (8)
Shegan Gao, Doctor (4) · Tanyou Shan, Master (4) · Xiaozhi Yuan, Master (4) · Aimery de Gramont, MD (3) · Dan Wang, Master (3) · Enders K.W. Ng, MD (3) · Guoqiang Kong, Master (3) · Jiachun Sun, Doctor (3) · Jing Ren, Master (3) · Ruina Yang, Master (3) · Ruinuo Jia, Master (3) · Shiyuan Song, Master (3) · Wei Wang, Master (3) · Weijiao Yin, Master (3) · Xiaoshan Feng, Doctor (3)
PMID 20718753, PMID 22895629, PMID 23148692, PMID 23599758, PMID 24224128, PMID 24371038, PMID 25077927, PMID 26363929, PMID 26805559, PMID 27223606, PMID 27266524, PMID 27742014, PMID 36306483, PMID 40013523, PMID 41252656, PMID 41379261, PMID 10400410, PMID 10789750, PMID 10987278, PMID 11231246, PMID 11239312, PMID 11413430, PMID 11491192, PMID 11813623, PMID 11895791, PMID 11914441, PMID 12047964, PMID 12510709, PMID 14531531, PMID 14598268, PMID 14673047, PMID 15131807, PMID 15273542, PMID 15711856, PMID 1598671, PMID 16103468, PMID 16110036, PMID 16235286, PMID 16427380, PMID 16475046, PMID 16624552, PMID 16810012, PMID 16876399, PMID 17005947, PMID 17013448, PMID 17085003, PMID 17336514, PMID 17427539, PMID 17538089, PMID 17859247
2015 (2), 2005 (1), 2009 (1), 2014 (1), 2018 (1), 2019 (1), 2023 (1), K08HD052885 (1), P30CA006516 (1), U10CA031946 (1)